儿童瘤学小组2023年研究蓝图:骨髓状瘤
Todd M Cooper1, Todd A Alonzo2, Sarah K Tasian3
1Department of Pediatrics, Seattle Children's Hospital Cancer and Blood Disorders Service, University of Washington School of Medicine, Seattle, Washington, USA.
Pediatric blood & cancer
|July 21, 2023
概括
儿科急性髓性白血病 (AML) 的存活率已经停滞不前,但针对性疗法如gemtuzumab ozogamicin和sorafenib对特定突变显示出希望. 风险分层和支持性护理方面的进展旨在改善AML儿童的治疗结果,并降低AML儿童的毒性.
科学领域:
- 儿科瘤学 儿科瘤学
- 血液学恶性瘤是什么
- 癌症治疗方法 癌症治疗方法
背景情况:
- 儿科急性髓性白血病 (AML) 的结果已经平稳,无事件的5年生存率 (EFS) 约为46%和总生存率 (OS) 约为64%.
- 高风险的儿科AML患者面临着特别糟糕的预后,其5年生存率仅为46%.
- 针对性治疗的最新进展为特定患者子组提供了潜在的生存改善.
研究的目的:
- 审查儿童急性髓性白血病 (AML) 治疗的最新进展.
- 突出针对性疗法,风险分层和支持性护理对患者结果的影响.
- 概述正在进行的研究议程,以提高儿童AML存活率.
主要方法:
- 对临床试验数据的审查,包括AAML0531和AAML1031.
- 针对性药物的影响分析,如gemtuzumab ozogamicin和 sorafenib.
- 检查细胞分子事件表征风险分层的进展.
- 评估不断发展的支持性护理策略.
主要成果:
- 吉姆图祖马布臭加米辛改善了KMT2A重组的AML和FLT3-ITD突变的结局.
- 索拉芬尼在患有FLT3-ITDAML的儿童中显示出了益处.
- 改进的风险分层有助于识别血造干细胞移植 (HSCT) 患者.
- 精细的支持性护理降低了毒性,改善了EFS和OS.
结论:
- 针对性治疗,改善风险分层和加强支持性护理对于改善儿科AML存活率至关重要.
- 持续的研究和将这些进步纳入标准护理预计将减少死亡率和发病率.
- 儿童瘤学小组的目标是通过持续的研究和战略进步来治疗更多患有AML的儿童.
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Bone Marrow Sampling and Transplants
360
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
360


